INCY实时信号 | 通过Getagraph.com最大化利润

出售 71 min ago

@ $62.55

发出时间: 26 Jun 2024 @ 23:22

回报率: -0.48%

上一信号: Jun 26 - 02:09

上一信号: 购买

回报率: -1.15 %

Live Chart Being Loaded With Signals

Commentary (27 Jun 2024 @ 00:33):
Our systems believe the stock currently is undervalued by 0.25% compare to its pairs and should correct upwards.

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally...

Stats
今日成交量	475 798
平均成交量	3.35M
市值	14.00B
EPS	$0.760 ( Q1 \| 2024-04-30 )
下一个收益日期	( $1.140 ) 2024-08-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	18.86 (Sector) 42.63 (Industry) 24.32
ATR14	$0.850 (1.37%)

AADI -3.24%

ABCL 1.47%

ABCM 0.04%

ABEO -2.61%

ABIO -3.08%

ABOS 0.70%

ABSI 1.87%

ABUS -1.80%

ABVX -1.50%

ACAD -0.58%

ACER -17.95%

ACET -4.76%

ACGN 1.29%

ACHL 1.59%

ACHV -0.75%

ACIU -0.75%

ACLX 0.80%

ACRV -2.31%

ACST -2.90%

ACXP 1.38%

ADAG 4.64%

ADAP -4.05%

ADGI 0.87%

ADIL 1.75%

ADMA -2.09%

ADPT 0.27%

ADTX -2.38%

ADVM -3.62%

ADXN -1.60%

AEON -2.94%

AEZS -2.49%

AFMD -2.01%

AGEN -1.82%

AGIO -2.39%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 0.54%

AKRO -3.21%

AKTX 1.45%

AKUS 0.00%

ALBO 0.00%

ALDX -2.10%

ALEC 0.88%

ALGS -0.74%

ALKS 0.27%

ALLK -9.70%

ALLO -5.65%

ALLR -0.48%

ALNA 3.16%

ALNY 2.41%

ALPN 0.02%

ALPX 0.00%

ALRN -1.33%

ALT -9.19%

ALVR 2.60%

ALXN 0.00%

ALXO -13.24%

ALZN 5.27%

AMRN -1.68%

AMTI -3.13%

ANAB 1.45%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX 0.87%

ANPC -3.15%

APGE -0.05%

APGN 8.48%

APGNW 30.65%

APLM -2.22%

APLS 0.29%

APLT -3.04%

APM 0.36%

APOP 0.38%

APRE 0.60%

APTO 5.98%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -4.79%

ARDS -14.23%

ARDX 0.25%

ARGX -0.90%

ARNA 0.00%

ARPO -0.90%

ARQT -0.83%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.07%

ARWR -0.78%

ASLN -3.83%

ASMB -5.81%

ASND -1.74%

ATAI -2.22%

ATHA 5.02%

ATHE 0.56%

ATHX -33.50%

ATNF 4.29%

ATOS 2.44%

ATRA -2.06%

ATXI -2.78%

ATXS -0.44%

AUPH -0.99%

AURA 2.79%

AUTL -1.72%

AVBP -1.89%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -3.48%

AVTX -1.25%

AVXL -4.07%

AXLA 0.00%

AXSM -1.08%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 2.52%

BCAB 5.56%

BCDA -2.23%

BCDAW -41.77%

BCEL 0.00%

BCLI 4.36%

BCRX 0.33%

BCTX 8.90%

BCTXW -16.32%

BCYC 0.80%

BDRX -4.62%

BDTX -1.28%

BEAM 1.09%

BFRA -2.91%

BGNE -2.78%

BIOR -6.17%

BIVI 3.41%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -0.78%

BLU 0.03%

BLUE 0.47%

BMEA -11.04%

BMRN 0.08%

BNOX 6.22%

BNTC -0.42%

BNTX -1.61%

BOLD -12.19%

BOLT -0.05%

BPMC -1.14%

BPTH 0.00%

BPTS -13.47%

BRNS 0.00%

BRTX -3.52%

BTAI 24.25%

BTTX 50.67%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 4.24%

CABA 1.66%

CADL -2.12%

CALA 0.00%

CALC -1.77%

CALT -1.59%

CAPR -1.72%

CARA -0.06%

CARM 13.11%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -4.78%

CCCC -6.06%

CCXI 0.00%

CDAK 0.00%

CDIO -2.18%

CDIOW 24.00%

CDMO -2.96%

CDMOP 0.04%

CDT -4.84%

CDTTW -39.60%

CDTX -1.31%

CDXC 0.82%

CDXS 7.40%

CELC -4.21%

CELU -1.00%

CELUW 11.80%

CERC -1.68%

CERE -1.42%

CERO -3.90%

CEROW -21.56%

CFRX -27.95%

CGEM -2.98%

CGEN -3.31%

CGON -1.40%

CGTX -4.55%

CHMA -6.00%

CHRS 1.89%

CINC 0.00%

CING -2.73%

CINGW 34.95%

CKPT -3.83%

CLBS -16.75%

CLDX -1.30%

CLGN 0.34%

CLLS -4.15%

CLNN 0.00%

CLNNW 0.00%

CLRB 6.30%

CLSD 0.00%

CLSN -0.68%

CLVS 0.00%

CMMB -0.98%

CMND 0.00%

CMPI 0.00%

CMPX -0.95%

CMRA 0.00%

CMRAW 33.33%

CMRX -3.48%

CNCE 0.00%

CNSP -35.92%

CNST 0.00%

CNTA -0.28%

CNTB 0.00%

CNTX -7.31%

COCP -2.00%

COEPW 32.45%

COGT -3.37%

CORT 2.80%

COYA -1.46%

CPRX -1.06%

CRBP -3.49%

CRBU -6.53%

CRDF -0.89%

CRGX -0.07%

CRIS -1.72%

CRNX -5.93%

CRSP 0.54%

CRTX 2.63%

CRVO -5.75%

CRVS 1.69%

CSBR -1.59%

CTCX -1.60%

CTIC 0.06%

CTMX -3.72%

CTNM -2.21%

CTXR 2.61%

CUE 5.84%

CVAC -5.20%

CVKD -2.85%

CWBR 2.80%

CYAD -12.96%

CYCC 9.09%

CYCCP 5.49%

CYCN -0.24%

CYT -2.27%

CYTK -2.08%

CYTO -1.82%

DARE 4.02%

DAWN -1.05%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 29.65%

DNLI -1.38%

DNTH -10.07%

DOMH 2.43%

DRMA -4.04%

DRMAW -1.25%

DRNA 0.00%

DRTS 3.45%

DRTSW 0.00%

DRUG 0.95%

DSGN -2.87%

DTIL 1.99%

DYAI 12.26%

EARS -1.77%

EDIT -2.52%

EDSA 3.19%

EFTR 5.11%

EFTRW -51.85%

EIGR -9.21%

ELAB -2.84%

ELDN 8.99%

ELEV -6.64%

ELOX -5.38%

ELTX -4.26%

ELVN -4.14%

ELYM 2.23%

ENGN -1.42%

ENGNW 0.00%

ENLV 2.90%

ENOB 1.79%

ENSC 3.23%

ENTA 0.08%

ENTO -2.42%

ENTX 1.60%

ENVB 1.58%

EPIX -2.36%

EPRX -1.15%

EPZM 0.00%

EQ 0.34%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -3.82%

ETON 1.83%

ETTX 0.00%

EVAX -2.14%

EVGN 4.76%

EVLO 0.00%

EWTX -0.29%

EXAI -1.13%

EXEL -0.04%

EYEG -0.69%

EYEN 1.41%

EYPT 0.36%

FATE -10.08%

FBIO 0.89%

FBIOP -0.37%

FBLG -15.40%

FBRX -0.02%

FDMT -3.32%

FENC -1.29%

FGEN -7.30%

FHTX 6.87%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -1.47%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.40%

FULC -3.51%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.25%

GANX -2.31%

GBIO -2.83%

GBT 0.01%

GDTC 0.50%

GERN -4.65%

GHRS -2.30%

GLMD -4.94%

GLPG -2.11%

GLSI 1.43%

GLTO -2.16%

GLUE -3.17%

GLYC -9.91%

GMAB -0.62%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -3.14%

GNLX -0.22%

GNPX 1.49%

GNTA 3.94%

GOSS -10.93%

GOVX 0.00%

GOVXW -49.04%

GPCR -7.26%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 1.48%

GRTX 5.14%

GTHX 0.91%

GUTS -4.39%

GXGXW 41.67%

GYRE -8.82%

HALO -1.34%

HARP 0.09%

HCWB -3.75%

HEPA -4.09%

HGEN -84.62%

HILS 5.66%

HLVX 0.15%

HOOK 2.33%

HOTH -3.51%

HOWL -1.50%

HRMY 1.85%

HRTX 4.26%

HSTO 0.00%

HUMA 0.57%

HUMAW -0.01%

IBRX -4.06%

ICCC -1.55%

ICPT 0.21%

ICU 19.10%

ICUCW 20.46%

ICVX -0.91%

IDRA -23.04%

IDYA -1.80%

IFRX -1.85%

IGMS -0.51%

IKNA 1.19%

IKT -0.35%

IMAB 2.33%

IMCR -2.89%

IMGN 0.02%

IMGO 0.00%

IMMP 3.97%

IMMX -8.15%

IMNM 0.52%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX 0.00%

IMTX -0.58%

IMTXW 6.00%

IMUX 1.85%

IMV 0.00%

IMVT -4.91%

INAB -0.01%

INBX 0.63%

INCY -1.35%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM 1.49%

INMB 1.82%

INO -1.37%

INSM -1.46%

INTS -2.75%

INVA 0.55%

INZY 0.80%

IOBT -10.34%

IONS 0.95%

IOVA -3.54%

IPA -0.49%

IPHA 5.58%

IPSC -2.54%

IRON -1.77%

ISEE 0.38%

ITOS -1.68%

ITRM 1.67%

IVA 6.96%

IVVD -2.88%

JAGX 1.18%

JANX -3.93%

JAZZ -0.57%

JNCE 0.00%

JSPR -6.17%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.54%

KALV -5.80%

KDNY 0.22%

KMPH -0.34%

KNSA -2.08%

KNTE -0.38%

KOD -6.72%

KPRX 0.96%

KPTI -5.05%

KRBP -10.00%

KRON 0.58%

KROS -1.07%

KRRO -8.11%

KRTX 0.03%

KRYS -0.37%

KTRA 9.58%

KTTA -6.79%

KTTAW 0.92%

KURA -0.24%

KYMR -2.95%

KYTX -3.88%

KZIA 2.65%

KZR -1.04%

LABP 0.57%

LBPH -1.74%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.75%

LENZ -5.05%

LEXX -0.77%

LEXXW -14.63%

LGND -0.50%

LGNDV 0.00%

LGVN -7.61%

LIAN -8.28%

LIFE 2.70%

LIPO -3.87%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 1.39%

LPCN -1.86%

LPTX -2.75%

LQDA -0.08%

LRMR -1.92%

LSTA -4.06%

LTRN 1.37%

LUMO -1.32%

LVTX -1.03%

LXEO -4.08%

LXRX -2.06%

LYEL -36.30%

LYRA 1.16%

MACK 0.10%

MBIO -9.20%

MBRX -1.72%

MCRB 2.46%

MDGL -1.14%

MDNA -13.16%

MDWD -0.14%

MDXG -2.58%

MEIP 1.40%

MESO -1.26%

MGNX -2.10%

MGTA -7.74%

MGTX -3.61%

MGX -4.02%

MIRM -1.30%

MIRO 0.59%

MIST 1.15%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX 0.25%

MLYS -7.64%

MNKD 0.31%

MNMD 0.14%

MNOV 2.11%

MNPR -8.52%

MOLN 2.47%

MOR 1.20%

MORF -3.22%

MREO -2.86%

MRKR 2.57%

MRNA -5.97%

MRNS -4.41%

MRSN -2.15%

MRTX -0.17%

MRUS 0.21%

MRVI -1.16%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -0.93%

MYMD 5.75%

NAMS 3.32%

NAMSW -0.21%

NAUT 1.55%

NBRV 0.71%

NBSE -1.56%

NBTX 12.09%

NCNA 0.73%

NERV -0.63%

NEXI 1.84%

NGM -1.28%

NGNE -1.41%

NKGN 10.08%

NKGNW 8.00%

NKTR -3.74%

NKTX -5.06%

NLSP 5.88%

NLSPW 26.67%

NMRA -2.86%

NMTR -42.97%

NOVN -24.84%

NRBO 7.28%

NRIX -2.31%

NRSN -5.12%

NRSNW 0.00%

NRXP -3.72%

NRXPW 18.33%

NRXS 4.82%

NTBL 4.01%

NTEC -12.45%

NTHI 0.00%

NTLA -6.75%

NTRBW -31.07%

NUVL -2.01%

NVAX -2.29%

NVCT 3.55%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 1.32%

OABIW -10.06%

OBIO -3.07%

OBSV 0.00%

OCEA 0.00%

OCGN 2.12%

OCS -1.00%

OCUL -0.08%

OCUP 1.84%

ODT -4.27%

OKYO 1.51%

OLMA -5.29%

OMER -1.16%

OMGA 5.64%

ONCO 4.04%

ONCR -3.08%

ONCS 31.87%

ONCT -3.05%

ONCY 0.99%

ONTX -0.47%

ONVO 1.32%

OPNT 0.00%

OPT 3.09%

ORGS 0.96%

ORIC -3.56%

ORMP 17.83%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -2.43%

OVID 1.41%

OYST 0.00%

PALI 1.30%

PASG -1.30%

PBLA -7.50%

PBM -3.48%

PBYI 1.18%

PCSA 0.00%

PCVX -0.39%

PDSB -3.16%

PEPG 1.37%

PGEN -2.69%

PHAR 1.51%

PHAS 0.00%

PHAT -1.06%

PHIO -3.57%

PHIOW 36.47%

PHVS -7.32%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.47%

PLUR 7.39%

PMN 0.72%

PMVP -0.89%

PNT 0.16%

PPBT -6.35%

PRAX 3.65%

PRDS 0.93%

PRLD -2.37%

PROG -3.47%

PROK 0.00%

PRQR -0.66%

PRTA -2.42%

PRTC 0.49%

PRTG 7.02%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -10.46%

PSTX -1.16%

PTCT -0.45%

PTE -0.82%

PTGX -0.87%

PTIXW -48.41%

PULM 2.60%

PXMD 4.76%

PYPD 0.07%

PYXS 0.33%

QLGN -3.00%

QNCX 5.70%

QNRX -1.14%

QSI -11.97%

QSIAW -3.13%

QTTB -3.45%

QURE -0.78%

RAIN -1.63%

RANI 6.42%

RAPT -1.30%

RARE 1.55%

RCKT -8.68%

REGN 0.28%

RENB -3.11%

REPL -2.38%

RETA 0.02%

REUN -0.89%

REVB -2.79%

REVBU 3.46%

REVBW 5.00%

RGLS -6.76%

RGNX -5.88%

RIGL -3.29%

RLAY -4.00%

RLMD 0.35%

RLYB -1.34%

RNA 0.49%

RNAC -2.94%

RNAZ -1.90%

RNXT 0.89%

ROIV -2.08%

ROIVW 4.56%

RPHM -0.93%

RPRX 0.28%

RPTX -0.29%

RUBY 2.70%

RVLP -32.05%

RVMD -1.13%

RVMDW -30.00%

RVNC 0.21%

RVPH -1.98%

RVPHW 1.62%

RXDX 0.09%

RXRX -4.05%

RYTM -5.60%

RYZB 0.02%

RZLT 3.09%

SABS -1.37%

SABSW -11.81%

SAGE 1.24%

SANA -3.79%

SAVA -0.16%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -0.06%

SCPH 5.05%

SCPS 0.00%

SEEL -4.08%

SEER 0.29%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -0.38%

SGMT -2.42%

SGTX -2.56%

SIOX 22.63%

SLDB -9.14%

SLGL 4.12%

SLN -4.57%

SLNO -4.35%

SLRX 5.27%

SLS -1.71%

SMMT -1.31%

SNDX 1.18%

SNGX -4.91%

SNPX -4.39%

SONN 0.00%

SPPI -0.49%

SPRB 0.63%

SPRC -2.75%

SPRO 0.05%

SRNE -34.00%

SRPT -0.98%

SRRA 0.00%

SRRK -1.98%

SRZN -2.45%

STAB 0.00%

STOK -5.52%

STRO -3.34%

STSA 0.00%

STTK -1.69%

SURF -0.93%

SVRA -8.54%

SWTX -0.22%

SYBX -1.29%

SYRS -1.55%

TALS -0.73%

TARA -7.62%

TARS 0.39%

TBPH 0.54%

TCBP 2.48%

TCDA 0.00%

TCON 2.46%

TCRR 0.00%

TCRT 0.08%

TCRX -1.45%

TECH -0.10%

TENX 1.91%

TERN -8.54%

TFFP -5.33%

TGTX -4.28%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -4.60%

TNGX -3.67%

TNXP -6.40%

TNYA -4.73%

TPST 4.89%

TRDA -4.06%

TRVI 2.30%

TRVN 4.12%

TSHA -22.87%

TSVT -3.46%

TTNP -7.66%

TVTX 1.51%

TYRA -8.54%

UBX -2.84%

UNCY -3.94%

URGN -1.15%

UTHR 0.56%

VACC 11.36%

VALN -4.07%

VAXX 115.63%

VBIV 0.33%

VBLT -8.77%

VCEL 0.96%

VCNX 10.35%

VCYT -1.61%

VERA -4.20%

VERU 0.97%

VERV -2.96%

VIGL 4.84%

VINC 2.28%

VIR 0.87%

VIRI -1.73%

VIRX 3.15%

VKTX -1.63%

VLON -13.04%

VNDA -3.42%

VOR -1.61%

VRCA 0.07%

VRDN -4.69%

VRNA -0.47%

VRPX 0.38%

VRTX 0.28%

VSTM -1.32%

VTGN -1.81%

VTVT -2.97%

VTYX -2.08%

VXRT -5.57%

VYGR -0.26%

VYNE -4.62%

VYNT 7.78%

WINT 2.18%

WVE -6.39%

XBIO 1.03%

XBIT -2.05%

XCUR 3.55%

XENE -0.97%

XERS 2.37%

XFOR 4.17%

XLO 3.88%

XLRN 0.00%

XNCR 0.40%

XOMA -3.23%

XOMAO -0.16%

XOMAP -0.82%

XRTX -8.00%

YMAB -1.72%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.67%

ZNTL -2.14%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-12	Baker Bros. Advisors Lp	Buy	2 830	Common Stock
2024-06-12	Baker Bros. Advisors Lp	Sell	5 283 206	Common Stock
2024-06-12	Baker Bros. Advisors Lp	Buy	2 830	Common Stock
2024-06-12	Baker Bros. Advisors Lp	Sell	175 977	Common Stock
2024-06-12	Baker Bros. Advisors Lp	Buy	12 517	Non- Qualified Stock Options (right to buy)

INSIDER POWER
-77.59
Last 98 transactions
Buy: 962 698 \| Sell: 5 597 088

相关性 (AI algo v.1.1b): Undervalued: 0.25% $62.41 paired level. (算法实时跟踪最相关股票的变化并提供即时更新)

音量相关性

長: -0.52 (weak negative)

短: -0.80 (moderate negative)

Signal:(27) Neutral

Incyte Corp 相关性

10 最正相关
ADPT	0.947
NDLS	0.938
NEOG	0.928
RNW	0.928
BIGC	0.926
CWCO	0.924
DCFC	0.923
MAXN	0.923
CLNE	0.922
NVTS	0.922

10 最负相关
SWAV	-0.903
TAYD	-0.895
IVCB	-0.887
BCSA	-0.887
FTGC	-0.883
JVA	-0.882
KINS	-0.88
MTEK	-0.873
EML	-0.871
LPCN	-0.869

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Incyte Corp 相关性 - 货币/商品

-0.26
( neutral )

0.65
( moderate )

0.00
( neutral )

-0.35
( neutral )

0.00
( neutral )

0.57
( weak )

Incyte Corp 财务报表

Annual	2023
营收:	$3.70B
毛利润:	$3.44B (93.10 %)
EPS:	$2.67

FY	2023
营收:	$3.70B
毛利润:	$3.44B (93.10 %)
EPS:	$2.67

FY	2022
营收:	$3.39B
毛利润:	$3.19B (93.90 %)
EPS:	$1.530

FY	2021
营收:	$2.99B
毛利润:	$2.84B (94.94 %)
EPS:	$4.30

Financial Reports:

No articles found.

Incyte Corp Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Incyte Corp

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia. Its clinical stage products include ruxolitinib, a steroid-refractory chronic graft-versus-host-diseases (GVHD); itacitinib, which is in Phase II/III clinical trial to treat naïve chronic GVHD; and pemigatinib for treating bladder cancer, cholangiocarcinoma, myeloproliferative syndrome, and tumor agnostic. In addition, the company engages in developing Parsaclisib, which is in Phase II clinical trial for follicular lymphoma, marginal zone lymphoma, and mantel cell lymphoma. Additionally, it develops Retifanlimab that is in Phase II clinical trials for MSI-high endometrial cancer, merkel cell carcinoma, and anal cancer, as well as in Phase II clinical trials for patients with non-small cell lung cancer. It has collaboration agreements with Novartis International Pharmaceutical Ltd.; Eli Lilly and Company; Agenus Inc.; Calithera Biosciences, Inc; MacroGenics, Inc.; Merus N.V.; Syros Pharmaceuticals, Inc.; Innovent Biologics, Inc.; Zai Lab Limited; Cellenkos, Inc.; and Nimble Therapeutics, as well as clinical collaborations with MorphoSys AG and Xencor, Inc. to investigate the combination of tafasitamab, plamotamab, and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma, and relapsed or refractory follicular lymphoma. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware.